Virtual population generator for human cardiomyocytes parameters: In silico drug cardiotoxicity assessment

Toxicology Mechanisms and Methods

Volumn 22, Issue 1, 2012, Pages 31-40

  Polak, Sebastian ^a   Fijorek, Kamil ^b   Glinka, Anna ^a   Wisniowska, Barbara ^a   Mendyk, Aleksander ^a  

^a JAGIELLONIAN UNIVERSITY   (Poland)

^b CRACOW UNIVERSITY OF ECONOMICS   (Poland)

Author keywords

age correlation; Cardiomyocyte; cardiomyocyte electric capacitance; cardiomyocyte volume; virtual population

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOMYOCYTE SURFACE AREA; CARDIOMYOCYTE VOLUME; CARDIOTOXICITY; CARDIOVASCULAR PARAMETERS; COMPUTER MODEL; ELECTRIC CAPACITANCE; HEART LEFT VENTRICLE; HEART MUSCLE CELL; HEART MUSCLE POTENTIAL; HUMAN; HUMAN CELL; NORMAL HUMAN; PRIORITY JOURNAL; VIRTUAL REALITY;

AGING; CARDIAC ELECTROPHYSIOLOGY; CELL SIZE; CELLS, CULTURED; COMPUTER SIMULATION; ELECTRIC CAPACITANCE; HEART VENTRICLES; HUMANS; MEMBRANE POTENTIALS; MODELS, BIOLOGICAL; MYOCYTES, CARDIAC; PHARMACEUTICAL PREPARATIONS; TOXICITY TESTS;

EID: 83455253531     PISSN: 15376516     EISSN: 15376524     Source Type: Journal    
DOI: 10.3109/15376516.2011.585477     Document Type: Article

References (44)

1. Anversa P, Reiss K, Kajstura J, Cheng W, Li P, Sonnenblick EH, Olivetti G. 1995. Myocardial infarction and the myocyte IGF1 autocrine system. Eur Heart J 16 (Suppl N):37-45.
2. Astorri E, Bolognesi R, Colla B, Chizzola A, Visioli O. 1977. Left ventricular hypertrophy: A cytometric study on 42 human hearts. J Mol Cell Cardiol 9:763-775.
3. Bois FY, Jamei M, Clewell HJ. 2010. PBPK modelling of inter-individual variability in the pharmacokinetics of environmental chemicals. Toxicology 278:256-267.
4. Borrud LG, Flegal KM, Looke AC. 2010. Body composition data for individuals 8 years of age and older: U.S. population, 1999- 2004. National Center for Health Statistics. Vital Health Stat 11. [Online] Available at: Http://www.cdc.gov/nchs/data/series/sr-11/sr11-250.pdf
5. Cain PA, Ahl R, Hedstrom E Ugander M, Allansdotter-Johnsson A, Friberg P, Arheden H. 2009. Age and gender specific normal values of left ventricular mass, volume and function for gradient echo magnetic resonance imaging: A cross sectional study. BMC Med Imaging 9. [Online] Available at: Http://www. biomedcentral. com/1471-2342/9/2/abstract/
6. Cain PA, Ahl R, Hedstrom E, Ugander M, Allansdotter-Johnsson A, Friberg P, Marild S, Arheden H. 2007. Physiological determinants of the variation in left ventricular mass from early adolescence to late adulthood in healthy subjects. Clin Physiol Funct Imaging 27:255-262.
7. Carroll MD, Lacher DA, Sorlie PD, Cleeman JI, Gordon DJ, Wolz M, Grundy SM, Johnson CL. 2005. Trends in serum lipids and lipoproteins of adults, 1960-2002. JAMA 294:1773-1781.
8. Chen A, Moy VT. 2000. Cross-linking of cell surface receptors enhances cooperativity of molecular adhesion. Biophys J 78:2814-2820.
9. Garny A. COR (Cellular Open Resource). [Online] Available at: Http://cor.physiol.ox.ac.uk/
10. Gerdes AM, Kellerman SE, Moore JA, Muffly KE, Clark LC, Reaves PY, Malec KB, McKeown PP, Schocken DD. 1992. Structural remodeling of cardiac myocytes in patients with ischemic cardiomyopathy. Circulation 86:426-430.
11. Grajek S, Lesiak M, Pyda M, Zajac M, Paradowski S, Kaczmarek E. 1993. Hypertrophy or hyperplasia in cardiac muscle. Post-mortem human morphometric study. Eur Heart J 14:40-47.
12. Greene WH. 2003. Econometric Analysis. Pearson Education Inc., Upper Saddle River, NJ.
13. Hine R. 1999. The Facts on File Dictionary of Biology. Market House Books, ISBN 0-8160-5647-1.
14. Itzhaki I, Maizels L, Huber I, Zwi-Dantsis L, Caspi O, Winterstern A, Feldman O, Gepstein A, Arbel G, Hammerman H, Boulos M, Gepstein L. 2011. Modelling the long QT syndrome with induced pluripotent stem cells. Nature 471:225-229.
15. Jaroszyk F. 2001. Biofizyka. Wydawnictwo Lekarskie PZWL, ISBN 83-200-2722-5.
16. Kuchel PW, Ralston GB. 1998. Theory and Problems of Biochemistry. McGraw-Hill, New York, ISBN 0-07-036149-5.
17. Lollikea K, Lindaub M. 1999. Membrane capacitance techniques to monitor granule exocytosis in neutrophils. J Immunol Meth 232:111-120.
18. Mandarim-de-Lacerda CA, das Santos MB, Le Floch-Prigent P, Narcy F. 1997. Stereology of the myocardium in human foetuses. Early Hum Dev 48:249-259.
19. Mirams GR, Cui Y, Sher A, et al. 2011. Simulation of multiple ion channel block provides improved early prediction of compounds' clinical torsadogenic risk. Cardiovasc Res first published online February 7, doi: 10.1093/cvr/cvr044.
20. Molleman A. 2007. Patch Clamping: An Introductory Guide to Patch Clamp Electrophysiology. Wiley, New York, ISBN 13:978-0-471- 48658-5 (PB).
21. Motta P, Pons N, Pagliarusco S, Pellegatti M, Bonomo F. 2011. Casopitant: In vitro data and SimCyp simulation to predict in vivo metabolic interactions involving cytochrome P450 3A4. Drug Metab Dispos 39:363-372.
22. NCHS (National Center for Health Statistics). Health, United States, 2009. With Special Feature on Medical Technology. Hyattsville, MD. 2010. Available at: www.cdc.gov/nchs/data/hus/hus09.pdf
23. Niederer SA, Fink M, Noble D, Smith NP. 2009. A meta-analysis of cardiac electrophysiology computational models. Exp Physiol 94:486-495.
24. Obiol-Pardo C, Gomis-Tena J, Sanz F, Saiz J, Pastor M. 2011. A multiscale simulation system for the prediction of drug-induced cardiotoxicity. J Chem Inf Model 51:483-492.
25. Olivetti G, Giordano G, Corradi D, Melissari M, Lagrasta C, Gambert SR, Anversa P. 1995. Gender differences and aging: Effects on the human heart. J Am Coll Cardiol 26:1068-1079.
26. Olivetti G, Melissari M, Balbi T, Quaini F, Cigola E, Sonnenblick EH, Anversa P. 1994a. Myocyte cellular hypertrophy is responsible for ventricular remodelling in the hypertrophied heart of middle aged individuals in the absence of cardiac failure. Cardiovasc Res 28:1199-1208.
27. Olivetti G, Melissari M, Balbi T, Quaini F, Sonnenblick EH, Anversa P. 1994b. Myocyte nuclear and possible cellular hyperplasia contribute to ventricular remodeling in the hypertrophic senescent heart in humans. J Am Coll Cardiol 24:140-149.
28. Oltedal L, Hartveit E. 2010. Transient release kinetics of rod bipolar cells revealed by capacitance measurement of exocytosis from axon terminals in rat retinal slices. J Physiol (Lond) 588:1469-1487.
29. Pangonyte D, Stalioraityte E, Ziuraitiene R, Kazlauskaite D, Palubinskiene J, Balnyte I. 2008. Cardiomyocyte remodeling in ischemic heart disease. Medicina (Kaunas) 44:848-854.
30. Pangonyte D, Stalioraityte E, Žiuraitiene R, Palubinskiene J, Kazlauskaite D. 2006. Ischemic asymptomatic left ventricular dysfunction: Myocardial substrate. Semin Cardiol 12:136-140.
31. Polak S, Jamei M, Rostami-Hodjegan A. 2011. Combining In Vitro-In Vivo Extrapolation (IVIVE) and Physiologically-based Pharmacokinetics (PBPK) with Drug Related Risk Assessment: Putting Pieces Together for a priori Assessment of the Likelihood of Cardiotoxicity. ACoP Conference abstracts. Available at: Http://www.go-acop.org/sites/default/files/webform/Sebastian-Polak.doc
32. Poole-Wilson PA. 1995. The dimensions of human cardiac myocytes; confusion caused by methodology and pathology. J Mol Cell Cardiol 27:863-865.
33. R Development Core Team. 2008. R: A Language and Environment for Statistical Computing, R Foundation for Statistical Computing. Vienna, Austria, ISBN 3-900051-07-0. Available at: Http://www.Rproject. org/
34. Rekic D, Röshammar D, Mukonzo J, Ashton M. 2011. In silico prediction of efavirenz and rifampicin drug-drug interaction considering weight and CYP2B6 phenotype. Br J Clin Pharmacol 71:536-543.
35. Rostami-Hodjegan A, Tucker GT. 2007. Simulation and prediction of in vivo drug metabolism in human populations from in vitro data. Nat Rev Drug Discov 6:140-148.
36. Rotroff DM, Wetmore BA, Dix DJ, Ferguson SS, Clewell HJ, Houck KA, Lecluyse EL, Andersen ME, Judson RS, Smith CM, Sochaski MA, Kavlock RJ, Boellmann F, Martin MT, Reif DM, Wambaugh JF, Thomas RS. 2010. Incorporating human dosimetry and exposure into high-throughput in vitro toxicity screening. Toxicol Sci 117:348-358.
37. Sakman B, Neher E. 2009. Single-Channel Recording. Springer.
38. Tang Y, Nyengaard JR, Andersen JB, Baandrup U, Gundersen HJ. 2009. The application of stereological methods for estimating structural parameters in the human heart. Anat Rec (Hoboken) 292:1630-1647.
39. ten Tusscher KH, Noble D, Noble PJ, Panfilov AV. 2004. A model for human ventricular tissue. Am J Physiol Heart Circ Physiol 286:H1573-H1589.
40. Vandenbeuch A, Zorec R, Kinnamon SC. 2010. Capacitance measurements of regulated exocytosis in mouse taste cells. J Neurosci 30:14695-14701.
41. Vliegen HW, van der Laarse A, Cornelisse CJ, Eulderink F. 1991. Myocardial changes in pressure overload-induced left ventricular hypertrophy. A study on tissue composition, polyploidization and multinucleation. Eur Heart J 12:488-494.
42. Xavier-Vidal R, Madi K. 1999. Comparison between right and left ventricular myocardia during the human fetal period. Stereological evaluation. Arq Bras Cardiol 72:581-592.
43. Zafeiridis A, Jeevanandam V, Houser SR, Margulies KB. 1998. Regression of cellular hypertrophy after left ventricular assist device support. Circulation 98:656-662.
44. Zhao P, Zhang L, Grillo JA, Liu Q, Bullock JM, Moon YJ, Song P, Brar SS, Madabushi R, Wu TC, Booth BP, Rahman NA, Reynolds KS, Gil Berglund E, Lesko LJ, Huang SM. 2010. Applications of physiologically based pharmacokinetic (PBPK) modeling and simulation during regulatory review. Clin Pharmacol Ther 89:259-267.